Marea Therapeutics

Acquired

Marea Therapeutics was founded in 2024, is headquartered in South San Francisco, United States, lists 11–50 employees, and has 2 recorded funding rounds.

Employees
11–50
Founded
2024
Business Model
B2B
Last Round
Series BJun 2024
Rounds
2
Acquisition Date
Sep 2026

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases. Incubated by Third Rock Ventures and launched in 2024, the company's lead program MAR001 is in Phase 2 clinical development for adults with metabolic dysfunction and high cardiovascular risk, while MAR002 is advancing toward the clinic for acromegaly. The company is headquartered in South San Francisco and led by a team of scientists and biopharma executives with deep expertise in cardioendocrine biology and human genetics.

Summary

Marea Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2024. It lists 11–50 employees. Its most recent funding was a Series B round in Jun 2024. Investors include Sofinnova Investments, Forbion Capital Partners and Third Rock Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionSep 2026

Sign up to see all 3 events

Funding: Series B through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Marea Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/marea-therapeutics"><img src="https://indexed.vc/api/badge/company/marea-therapeutics" alt="Marea Therapeutics on Indexed.vc" width="260" height="76" /></a>